GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable shift in how we treat type 2 diabetes . These new medications work by mimicking the body’s natural GLP-1 process, which https://siobhanymls670669.bloggactivo.com/40986815/glp-1-a-revolutionary-advance-in-diabetes-management